The GRE exam is no longer a requirement for admission into the QA/RA program or the non-thesis MS in Pharmaceutics program for students who earned a 3.0 Undergraduate GPA.
After reviewing years of data on QA/RA graduates, we have come to the conclusion that the GRE, although a useful indicator for some academic programs, does not accurately predict the success of students pursuing a professional master's curriculum such as Temple's QA/RA graduate program. Therefore, starting with students applying for admission into the QA/RA master's program for the spring 2012 semester, the GRE will no longer be required for students who have earned a 3.0 GPA (on a 4.0 scale) in their undergraduate bachelor's degree. This new ruling will also apply to students who wish to pursue the non-thesis MS in Pharmaceutics.
If a student did not attain a 3.0 GPA or higher at the undergraduate level, that individual may be considered for admission after taking three QA/RA graduate courses (or 9 semester hours) and earning a minimum grade of B+ or higher in each of the three courses. For more information, please see the Applying link.
To be considered for admission to the Master of Science in QA/RA, you must:
Submitting these materials does not guarantee admission. Members of the Graduate Admissions Committee will review all applications and make offers of admissions based on the above criteria. However, it is possible that other factors may be considered.
*Starting with the January 2012 semester, students who do not have an undergraduate GPA of 3.0 or higher may gain admission by taking 3 courses (9 credits) in the QA/RA Program and earning a B+ or higher in each of the first three courses.